STK11 and neoplasm: In colorectal cancer, where a murine isograft model was used, STK11 modulated TGFβ signalling, which mediated the exclusion of T-cells and suppressed the differentiation of Th1 cells, resulting in a “cold” tumour immune microenvironment [43].